Malaria prophylactic medication exposure and associated maternal, fetal, and infant outcomes
Ended Cooperative Agreement Awarded Last action
- Award ID
- HT94252320034
- Recipient
-
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. UEI UYLKBRENAPG5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $752,148
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Westlake, MD 20817, USA
Award details come from USAspending.gov.
About this award
The Department of Defense's Defense Health Agency awarded a $752,148 Cooperative Agreement on September 15, 2023 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project investigating the maternal, fetal, and infant outcomes associated with malaria prophylactic medication exposure. The work will be performed in Westlake, MD. The Henry M. Jackson Foundation, a global non-profit organization that frequently serves as a prime contractor and grantee for the DoD and other federal agencies, will execute this research project.
Quick answers
Who received award HT94252320034?
HT94252320034 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by Defense Health Agency (Department of Defense) on September 15, 2023.
How much is award HT94252320034 worth?
$752,148 has been obligated on HT94252320034.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award